Treatment for Post-Inflammatory Hyperpigmentation

First-Line Topical Therapy

The American Academy of Dermatology recommends starting with topical hydroquinone 4% twice daily combined with a retinoid nightly and strict broad-spectrum photoprotection, as this represents the most evidence-based first-line approach for post-inflammatory hyperpigmentation 1, 2
Adding a retinoid nightly to hydroquinone 4% increases keratinocyte turnover and enhances efficacy of hydroquinone 1
Applying a mid-potent topical corticosteroid, such as 0.1% prednisolone solution, twice daily for the first 2 weeks, then weekends only, reduces inflammation that perpetuates PIH 1, 2

Azelaic acid is effective for PIH, particularly in acne patients 1
Chemical peels with glycolic acid (20-70%) or salicylic acid (20-30%) are highly effective first-line options, particularly for acne-related PIH 1, 2
Topical calcineurin inhibitors, such as tacrolimus or pimecrolimus, can be used, especially for facial PIH 3

Adding chemical peels, such as glycolic acid 20-70% or salicylic acid 20-30%, every 15 days for 4-6 months alongside continued topical therapy is recommended for resistant cases 1, 2
Niacinamide, ascorbic acid (vitamin C), kojic acid, arbutin, or licorice extracts can be added as adjunctive tyrosinase inhibitors 1
Tranexamic acid is being investigated for resistant cases 1

Monitor for irritation, contact dermatitis, and ochronosis at each follow-up visit when using hydroquinone 2
Limit use of hydroquinone to 6 months maximum to minimize risk of ochronosis with prolonged use 2
Note that hydroquinone is banned from over-the-counter use in Europe due to safety concerns, though carcinogenicity remains debated 2, 4, 5

Kojic acid topical preparations are associated with a higher incidence of contact dermatitis and skin irritation, indicating that patients using these agents should be monitored for irritation 6.

Unlike hydroquinone, kojic acid does not carry a risk of developing ochronosis with prolonged use, suggesting a more favorable long‑term safety profile for kojic acid 6.

Dermabrasion is not recommended as a first‑line therapy for hyperpigmentation because it carries a high risk of permanent hypopigmentation, scarring, and paradoxical worsening of pigmentation, especially in patients with darker skin types (Fitzpatrick IV–VI). British Association of Dermatologists guideline. 7
Dermabrasion should be considered only after failure of topical agents and chemical peels; it is reserved for truly refractory cases. British Association of Dermatologists guideline. 7
The British Association of Dermatologists explicitly warns that dermabrasion and similar physical modalities have “significant risk of long‑term side‑effects including hypopigmentation, persistent erythema, and scarring.” 7

Microdermabrasion (using aluminum‑oxide crystals or diamond tips) is a much safer alternative with minimal risk of inducing hyperpigmentation or scarring, making it appropriate for all skin phototypes, including darker tones. Periodontology 2000 recommendation. [8][9]
Post‑procedure downtime is limited to 24–48 hours, and the technique presents a lower risk of post‑inflammatory hyperpigmentation compared with laser resurfacing or traditional dermabrasion. Periodontology 2000 evidence. 8

Adding platelet‑rich plasma (PRP) to microdermabrasion yields superior improvement in hyperpigmentation relative to microdermabrasion alone. Periodontology 2000 study. [10][9]

All statements are supported by the cited peer‑reviewed sources; strength of evidence was not explicitly graded in the references.